DD280112A5 - Verfahren zur herstellung kristalliner formen eines 1-carbacephalosporins - Google Patents
Verfahren zur herstellung kristalliner formen eines 1-carbacephalosporins Download PDFInfo
- Publication number
- DD280112A5 DD280112A5 DD88320416A DD32041688A DD280112A5 DD 280112 A5 DD280112 A5 DD 280112A5 DD 88320416 A DD88320416 A DD 88320416A DD 32041688 A DD32041688 A DD 32041688A DD 280112 A5 DD280112 A5 DD 280112A5
- Authority
- DD
- German Democratic Republic
- Prior art keywords
- dmf
- formula
- solvate
- suspension
- solution
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D463/00—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D463/10—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
- C07D463/14—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hetero atoms directly attached in position 7
- C07D463/16—Nitrogen atoms
- C07D463/18—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof
- C07D463/20—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D463/22—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen further substituted by nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cephalosporin Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10576287A | 1987-10-07 | 1987-10-07 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DD280112A5 true DD280112A5 (de) | 1990-06-27 |
Family
ID=22307652
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DD88320416A DD280112A5 (de) | 1987-10-07 | 1988-10-03 | Verfahren zur herstellung kristalliner formen eines 1-carbacephalosporins |
Country Status (24)
| Country | Link |
|---|---|
| EP (1) | EP0311365A1 (cs) |
| JP (1) | JPH02270871A (cs) |
| KR (1) | KR890006643A (cs) |
| CN (1) | CN1032442A (cs) |
| AU (1) | AU605635B2 (cs) |
| BG (1) | BG47035A3 (cs) |
| CS (1) | CS270593B2 (cs) |
| DD (1) | DD280112A5 (cs) |
| DK (1) | DK553888A (cs) |
| FI (1) | FI884555L (cs) |
| HU (1) | HU205112B (cs) |
| IL (1) | IL87904A0 (cs) |
| MX (1) | MX13276A (cs) |
| MY (1) | MY103554A (cs) |
| NO (1) | NO884417L (cs) |
| NZ (1) | NZ226451A (cs) |
| OA (1) | OA09017A (cs) |
| PH (1) | PH26811A (cs) |
| PL (2) | PL163113B1 (cs) |
| PT (1) | PT88663B (cs) |
| RO (2) | RO105809B1 (cs) |
| RU (1) | RU1776260C (cs) |
| YU (1) | YU46700B (cs) |
| ZA (1) | ZA887408B (cs) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1334970C (en) * | 1987-10-06 | 1995-03-28 | Carol Elaine Pasini | Crystalline .beta.-lactam hydrate |
| NZ242556A (en) * | 1991-05-10 | 1993-08-26 | Lilly Co Eli | Preparation of carbacephem derivatives |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1472746A (en) * | 1973-07-05 | 1977-05-04 | Glaxo Lab Ltd | Cephalosporin compounds |
| US4160863A (en) * | 1977-04-07 | 1979-07-10 | Bristol-Myers Company | Process for the preparation of the crystalline monohydrate of 7-[D-α-aα-(p-hydroxyphenyl)acetamido]-3-methyl-3-cephem-4-carboxylic acid |
| JPS5672698A (en) * | 1979-11-14 | 1981-06-16 | Kyowa Hakko Kogyo Co Ltd | Preparation of optically active cephalosporin analogue |
| CA1334970C (en) * | 1987-10-06 | 1995-03-28 | Carol Elaine Pasini | Crystalline .beta.-lactam hydrate |
-
1988
- 1988-10-03 MY MYPI88001104A patent/MY103554A/en unknown
- 1988-10-03 ZA ZA887408A patent/ZA887408B/xx unknown
- 1988-10-03 YU YU184688A patent/YU46700B/sh unknown
- 1988-10-03 DD DD88320416A patent/DD280112A5/de not_active IP Right Cessation
- 1988-10-04 JP JP63251713A patent/JPH02270871A/ja active Pending
- 1988-10-04 NZ NZ226451A patent/NZ226451A/xx unknown
- 1988-10-04 DK DK553888A patent/DK553888A/da not_active Application Discontinuation
- 1988-10-04 FI FI884555A patent/FI884555L/fi not_active Application Discontinuation
- 1988-10-04 MX MX1327688A patent/MX13276A/es unknown
- 1988-10-04 AU AU23371/88A patent/AU605635B2/en not_active Ceased
- 1988-10-04 PH PH37637A patent/PH26811A/en unknown
- 1988-10-04 IL IL87904A patent/IL87904A0/xx unknown
- 1988-10-04 PT PT88663A patent/PT88663B/pt not_active IP Right Cessation
- 1988-10-04 BG BG085593A patent/BG47035A3/xx unknown
- 1988-10-04 RO RO145635A patent/RO105809B1/ro unknown
- 1988-10-04 RO RO1988135393A patent/RO102423B1/ro unknown
- 1988-10-05 RU SU884356612A patent/RU1776260C/ru active
- 1988-10-05 KR KR1019880012960A patent/KR890006643A/ko not_active Ceased
- 1988-10-05 PL PL88294911A patent/PL163113B1/pl unknown
- 1988-10-05 EP EP88309260A patent/EP0311365A1/en not_active Withdrawn
- 1988-10-05 CN CN88109139A patent/CN1032442A/zh active Pending
- 1988-10-05 NO NO88884417A patent/NO884417L/no unknown
- 1988-10-05 PL PL1988275092A patent/PL159766B1/pl unknown
- 1988-10-05 HU HU885170A patent/HU205112B/hu not_active IP Right Cessation
- 1988-10-05 OA OA59443A patent/OA09017A/xx unknown
- 1988-10-06 CS CS886665A patent/CS270593B2/cs unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CS666588A2 (en) | 1989-11-14 |
| NO884417D0 (no) | 1988-10-05 |
| ZA887408B (en) | 1990-06-27 |
| AU605635B2 (en) | 1991-01-17 |
| HUT48883A (en) | 1989-07-28 |
| PT88663A (pt) | 1989-07-31 |
| RU1776260C (ru) | 1992-11-15 |
| MY103554A (en) | 1993-07-31 |
| BG47035A3 (bg) | 1990-04-16 |
| PL275092A1 (en) | 1989-05-16 |
| CS270593B2 (en) | 1990-07-12 |
| RO102423B1 (en) | 1992-08-01 |
| HU205112B (en) | 1992-03-30 |
| NZ226451A (en) | 1990-10-26 |
| JPH02270871A (ja) | 1990-11-05 |
| CN1032442A (zh) | 1989-04-19 |
| DK553888D0 (da) | 1988-10-04 |
| NO884417L (no) | 1989-04-10 |
| OA09017A (fr) | 1991-03-31 |
| YU184688A (en) | 1990-04-30 |
| FI884555A7 (fi) | 1989-04-08 |
| FI884555L (fi) | 1989-04-08 |
| AU2337188A (en) | 1989-04-13 |
| EP0311365A1 (en) | 1989-04-12 |
| RO105809B1 (ro) | 1992-12-30 |
| PL159766B1 (pl) | 1993-01-29 |
| FI884555A0 (fi) | 1988-10-04 |
| PH26811A (en) | 1992-11-05 |
| KR890006643A (ko) | 1989-06-15 |
| PL163113B1 (pl) | 1994-02-28 |
| PT88663B (pt) | 1993-10-29 |
| DK553888A (da) | 1989-04-08 |
| MX13276A (es) | 1993-11-01 |
| YU46700B (sh) | 1994-04-05 |
| IL87904A0 (en) | 1989-03-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69318077T2 (de) | Triazolylthiomethylthiocephalosporin-Hydrochlorid, sein kristallines Hydrat und seine Herstellung | |
| DE3143219C2 (cs) | ||
| DE69720774T2 (de) | S-omeprazol in festform | |
| DE3888913T2 (de) | Kristallines beta-Lactam-Hydrat. | |
| DE69829511T2 (de) | Neuer Prozess zur Herstellung von S-Omeprazol-Magnesiumsalz-Trihydrat | |
| DE3037102A1 (de) | Verbesserungen bei cephalosporinantibiotika | |
| AU620659B2 (en) | Hydrate forms of 1-carbacephalosporin derivatives | |
| EP0049448A2 (de) | Beta-Lactamantibiotika, Verfahren zu deren Herstellung sowie sie enthaltende Mittel | |
| DE2819479C2 (cs) | ||
| DE69229339T2 (de) | Kristallines tiagabinehydrochlorid-monohydrat, seine herstellung und verwendung | |
| DE3780909T2 (de) | 7-((meta-substituiert)-phenylglycin)-1-carba-1-dethia-cephalosporine. | |
| DE60114028T2 (de) | Verfahren zur herstellung von wasserfreiem azithromycin | |
| DE69001111T2 (de) | Antikrebs-zusammensetzung. | |
| DE69826881T2 (de) | Neue indolcarboxamide, pharmazeutische zusammensetzungen und methoden zur hemmung von calpain | |
| DE69508962T2 (de) | Diclavulanat-salze mit diaminoether und verfahren zu deren herstellung | |
| DD261163A5 (de) | Verfahren zur reinigung von cephalosporin-antibiotika | |
| DE3139554C2 (cs) | ||
| DE3919259A1 (de) | Kristalline cephem-saeureadditionssalze und verfahren zu ihrer herstellung | |
| DE69118933T2 (de) | Kristallines Hydrochlorid eines neuen beta-Lactam-Antibiotikums und Verfahren zur Herstellung | |
| EP0514791B1 (de) | Kristalline Säureadditionssalze diastereomerenreiner 3-Cephem-4-carbonsäure-1-(2,2-dimethyl-propionyloxy)-ethylester | |
| DE3113150A1 (de) | Isophthalsaeurepicolylamidmonohydrat, verfahren zu seiner herstellung und dessen pharmazeutische verwendung | |
| EP0003286B1 (de) | Ergopeptidalkaloid-Derivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen | |
| DE69617027T2 (de) | Polymorphs von prodrug 6-n(l-ala-l-ala)-trovafloxacin | |
| DD253616A5 (de) | Verfahren zur herstellung von neuen pleunromutilinderivaten | |
| EP0181571A1 (de) | Kristalline Aminomethyl-Verbindung |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ENJ | Ceased due to non-payment of renewal fee |